Results 31 to 40 of about 18,119,282 (331)

Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway [PDF]

, 2021
Purpose - Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse.
Cairns, John Alexander, Akslen, Lars A, Moshina, Nataliia, Akslen, Lars Andreas, Larsen, Marthe, Botteri, Edoardo, Falk, Ragnhild S, Cairns, John A, Hofvind, Solveig, Falk, Ragnhild Sørum, Nataliia Moshina, Edoardo Botteri, Ragnhild S. Falk, John A. Cairns, Lars A. Akslen, Marthe Larsen, Solveig Hofvind   +16 more
core   +1 more source

Alternative Approaches to Quality-Adjusted Life-Year Estimation Within Standard Cost-Effectiveness Models: Literature Review, Feasibility Assessment, and Impact Evaluation.

Value in Health, 2020
OBJECTIVES The quality-adjusted life-year (QALY) has been long debated, but alternative estimation approaches have not been comprehensively evaluated.
J. Carlson, E. Brouwer, Eunice Kim, Phoebe Wright, R. B. McQueen   +4 more
semanticscholar   +1 more source

The effect of surfactant type on characteristics, skin penetration and anti-aging effectiveness of transfersomes containing amniotic mesenchymal stem cells metabolite products in UV-aging induced mice

Drug Delivery, 2022
Transfersome has been developed to enhance dermal delivery of amniotic mesenchymal stem cell metabolite products (AMSC-MP). AMSC-MP contains many growth factors for managing skin aging, thus improving the quality of an adjusted life year. This study aims
Andang Miatmoko, Nurul Ailda Marufah, Qothrin Nada, Noorma Rosita, Tristiana Erawati, Joni Susanto, Kusuma Eko Purwantari, Arif Nurkanto, Purwati, Widji Soeratri   +9 more
doaj   +1 more source

Putting the quality into quality-adjusted life years [PDF]

Journal of Public Health, 2003
Over recent decades, a great deal of effort has been devoted towards developing instruments that can be used to elicit health state values. All of these instruments are conceptually very different from one another and all suffer from serious inherent biases.
openaire   +2 more sources

Methods to Estimate Willingness-to-Pay Per Quality Adjusted Life Year as Cost-Effectiveness Threshold

Jurnal Manajemen dan Pelayanan Farmasi, 2018
Pharmacoeconomic studies, especially the cost-utility analysis method, require a cost-effectiveness threshold for interpretation of the cost-effectiveness ratios of the study. The cost-effectiveness threshold is determined by each country.
Tri Murti Andayani, Dwi Endarti, Susi Ari Kristina, Rifqi Rokhman   +3 more
doaj   +1 more source

"Blanket rules just don't work": Qualitative exploration of the relative value of child and adult quality-adjusted life year (QALY) gains for health technology assessment. [PDF]

Int J Technol Assess Health Care
“Blanket rules just don’t work”: Qualitative exploration of the relative value of child and adult Quality Adjusted Life Year (QALY) gains for health technology ...
Sellars M, Coast J, Lancsar E, Donaldson C, Carter SM.   +4 more
europepmc   +2 more sources

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies

Фармакоэкономика, 2018
The aim was to develop a methodology for determining the willingness to pay threshold (WTPT) and its upper limit value within the Russian health care system.Materials and methods. WTPT was calculated based on the shadow budget price (i. e.
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov   +5 more
doaj   +1 more source

A technique for approximating transition rates from published survival analyses

Cost Effectiveness and Resource Allocation, 2019
Background Quality-adjusted-life-years (QALYs) are used to concurrently quantify morbidity and mortality within a single parameter. For this reason, QALYs can facilitate the discussion of risks and benefits during patient counseling regarding treatment ...
Markian A. Pahuta, Joel Werier, Eugene K. Wai, Roy A. Patchell, Doug Coyle   +4 more
doaj   +1 more source

QALY losses for chronic diseases and its social distribution in the general population: results from the Belgian Health Interview Survey

BMC Public Health, 2022
Background The burden of chronic diseases is rapidly rising, both in terms of morbidity and mortality. This burden is disproportionally carried by socially disadvantaged population subgroups.
Lisa Van Wilder, Brecht Devleesschauwer, Els Clays, Johan Van der Heyden, Rana Charafeddine, Aline Scohy, Delphine De Smedt   +6 more
doaj   +1 more source

Income-related inequality in life-years and quality-adjusted life-years [PDF]

Journal of Health Economics, 2000
We estimate the income-related inequality in Sweden with respect to life-years and quality-adjusted life-years (QALYs). We use a large data set from Sweden with over 40,000 individuals followed up for 10-16 years, to estimate the survival and quality-adjusted survival in different income groups.
Gerdtham, Ulf-G., Johannesson, Magnus
openaire   +3 more sources